TIEFENBACHER GROUP is committed to becoming climate neutral
Tiefenbacher Group is committed to becoming climate neutral by the end of 2025 – sustainability contribution to make life better for people and planet
We are pleased to share that TIEFENBACHER GROUP is committed to becoming climate neutral by the end of 2025*. As a value-driven healthcare company, dedicated to improving the life of patients worldwide, we recognize the importance of taking action to address the urgent climate crisis we face today. To achieve this goal, we are implementing a comprehensive sustainability strategy that includes the following measures, among others:
As our biggest driver of the carbon footprint is energy consumption, large-scale solar panels will be installed on our manufacturing facilities in Cyprus and India. Any electricity that cannot be produced in-house and must be purchased will be purely green electricity. In addition, we are implementing energy saving and efficiency measures – especially at our production sites. Furthermore, all company vehicles will be exclusively electric in the future. With these measures, we will already achieve a great interim goal: reducing our emissions by 80% by January 2024.
We believe that this is not only the right thing to do for the planet but also the right thing to do for our business. Being commercially successful and operating responsibly by becoming climate neutral is how we generate sustainable returns. We look forward to sharing more updates on our progress towards this important goal in the coming months and years.
*Scope 1 and 2 according to GHG as well as business travel and employee commuting
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER: Renovation Headquarters in Hamburg /Germany
Tiefenbacher Group: Renovating Headquarters in Hamburg: novel ways of working in an agile, open-plan work space
Tiefenbacher Group is renovating the Headquarters in Hamburg for flexible working while maintaining the importance of the office as a place for collaboration and personal interaction
Did you know that Tiefenbacher Group is currently renovating its headquarters in Hamburg, Germany as a response to the novel ways of working? We are excited to share the first results of the restructuring and are pleased to bring the first changes to life. The newly designed building will be a modern and innovative workspace that reflects our culture of entrepreneurship, professional excellence, and openness. The open-floor concept promotes creativity, collaboration, and teamwork among our employees. Also, the office concept provides for a maximum democratic approach in all the rooms, including the management stuff rooms.
Additionally, the modernization allowed us for the new branding elements to be incorporated into the workspace. We believe that the new space, right on the banks of the river Elbe, provides a great working environment that supports the growth and wellbeing of our employees at the same time. With hybrid and at-home work the new normal for many people, Tiefenbacher wants to keep its workspace relevant and up to date.
Watch our short video to see the first changes with our new flexible work space. The interior turned out to be generally airy, transparent, filled with light. We´ll keep you posted on the progress and look forward to welcoming you to our new office space soon! The full modernization at our headquarters is expected to be completed in 2024.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER GROUP AT DCAT 2023 – THANKS FOR MEETING US IN NEW YORK CITY!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP
DCAT week 2023 – one of the world´s most important pharma events – has just come to an end. It was four very successful and inspiring days for TIEFENBACHER GROUP in New York City. What a pleasure to present our latest product portfolio and innovations and to connect with existing and potential new partners. Check out our short video to get some impressions from DCAT 2023!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER API + INGREDIENTS WISHES A HEALTHY NEW YEAR 2023
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Happy New Year 2023
From all over the world, we wish you a happy and healthy New Year 2023!
Tiefenbacher Group wishes a everyone a healthy New Year. We hope the year 2023 will be as successful and full of unique moments as the past one and we are looking forward to meeting you again in person all over the world!
In order to serve more than 80 national markets in the best possible way for our partners, we are particularly proud to have so many different nationalities and cultures at TIEFENBACHER GROUP. We are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. Watch our colleagues from our various locations sharing short New Year’s greetings in their respective national languages with you.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
Thanks for visiting us at CPhI 2022 in Frankfurt!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Three successful days at CPhI 2022 – Thank you for visiting us in Frankfurt!
CPhI 2022, the world`s leading pharma event, has just come to an end. It was wonderful to meet our valued customers and partners in person again. Our experts enjoyed three very successful days full of exciting meetings and inspiring discussions. It was a great pleasure to present TIEFENBACHER API´s latest ideas to to secure the pharmaceutical industry with high-quality solutions along the whole API value chain.
Thanks a lot for visiting us at our new booth representing TIEFENBACHER GROUP as a global health pioneer. We are already looking forward to seeing you next year in Barcelona at CPhI 2023!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER GROUP opens new manufacturing site in Cyprus
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: new manufacturing site in Cyprus for drug production
Did you know that TIEFENBACHER GROUP heavily invests in its in-house production capacities for high-quality pharmaceuticals? We continuously expand in novel technologies and capabilities to improve quality and boost productivity. Therefore we are excited to announce that our new manufacturing site in Cyprus was ceremoniously opened in mid-October. The “Delorbis” plant is one of the most modern pharmaceutical production site in the European Union. Its facilities are equipped with state-of-the art technologies for the manufacturing of oral dosage forms. This investment follows TIEFENBACHER GROUP´s strategy to strengthen its position as a global, fully integrated pharmaceutical company.
Check out our short video and get an impression of the festive inauguration of the new plant!
For further information about our portfolio and innovative health care solutions for a better tomorrow please contact TIEFENBACHER GROUP at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®
TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative products in five indications. OYSTA® aims to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and flexible dosing.
TIEFENBACHER GROUP and OnDosis today announced the launch of the OYSTA® brand. OYSTA® represents the extensive co-development portfolio of drug/device combinations that was initiated in September 2020 and covers several indications such as ADHD, Parkinson´s disease, transplantation, and pain medicines as well as rare pulmonary diseases. The first product, combining a stimulant with the proprietary dosage manager for patients with ADHD, is already planned for launch in the US in 2024. Other indications will stand in line as next wave developments. OYSTA® captures the essence of the value proposition of the products under development: a safe “shell” (proprietary dosage manager) to protect medicines formulated as “pearls” (pellets or granules) to allow for intuitive, flexible, and precise dosing. Through the OYSTA® collaboration, OnDosis will benefit from a partner with leading competence in pharmaceutical development, supply chain, and B2B commercialization, whilst TIEFENBACHER GROUP gets access to an innovative product concept with game-changing potential in the new era of individualization of treatments and digitalization in healthcare. “OYSTA® allows us to clearly position the products we are co-developing in conversation with commercialization partners as well as with health care professionals and end users. It is ultimately a sign that our common efforts to bring innovation to patients is getting closer to market” says Kristian Ruepp, Managing Director at TIEFENBACHER GROUP. “OYSTA® perfectly captures the essence of what we want to achieve together in this exciting collaboration: individualized dosing of solid oral medicines formulated as “pearls” and protected within a device “shell” which gives reassurance to patients, caregivers, and healthcare professionals. Under one name, we are co-developing a portfolio of innovative products as one team, with the ambition to revolutionize how patients take their medicines. That revolution is now accelerating” says Martin Olovsson, CEO at OnDosis.
TIEFENBACHER GROUP and OnDosis will first present the OYSTA® brand in public at CPhI 2022 in Frankfurt (Nov 1-3). To schedule a meeting please contact TIEFENBACHER GROUP via info@aet.eu.
About Tiefenbacher Group – Pioneering Healthcare since 1963
100% family owned since 1963 TIEFENBACHER GROUP is a global health care company providing innovative and best-in-class solutions along the entire pharmaceutical value chain. That includes the distribution of API ́s and the development, manufacturing, and registration of finished dosage forms. The world ́s most trusted health care brands count on TIEFENBACHER’s pioneer spirit as well as its pharmaceutical excellence. Leveraging its global presence including own laboratories and manufacturing sites, TIEFENBACHER is driven to make pharmaceuticals more affordable, more available, and better than before. There is one purpose driving TIEFENBACHER’s about 800 employees day by day: improving the life of millions of patients worldwide. www.tiefenbachergroup.com
For any request regarding a collaboration in one of the five indications mentioned above, please contact TIEFENBACHER GROUP. For interest in any other indication or solely the device please contact OnDosis:
Dr. Kristian Ruepp
Joint Managing Director, TIEFENBACHER GROUP
Tel: +49 40 – 44 18 09-0; info@aet.eu
About OnDosis
A Swedish Life science company that will revolutionize the way patients take their medicines. The idea is to deliver the perfect dosage — individualized, intuitive, and intelligent — in a form that is easier to consume. OnDosis has developed a proprietary technology platform that centers around a connected handheld device that delivers customized and easily adjusted doses of oral medicines and enables integration of digital technologies. By combining traditional drug-based treatments with digital therapeutics, OnDosis strives to fulfill its purpose: to ensure that patients get exactly the medicine they need, so they can live the lives they deserve. www.ondosis.com
Martin Olovsson
CEO, OnDosis
Tel: +46 76 772 85 01; m.olovsson@ondosis.com
OYSTA® is a registered trademark jointly owned by TIEFENBACHER GROUP and OnDosis. The OYSTA® products are co-developed based in the proprietary dosage manager device platform developed by OnDosis.
Meet TIEFENBACHER API + INGREDIENTS at CPhI 2022 in Frankfurt
Meet TIEFENBACHER API + INGREDIENTS at CPhI in Frankfurt from 1-3 Nov and discover to secure the pharmaceutical industry with high-quality API
We are very excited to meet our valued customers and partners once again on CPhI 2022, the world´s leading pharma industry event! Explore our new booth representing Tiefenbacher Group as a global health pioneer and discover our latest product portfolio and innovations in the field of high-quality APIs, finished dosage forms, and medical devices! Get in touch with our experts to discuss new business opportunities to secure the pharmaceutical industry with high-quality solutions along the whole API value chain
CPHI 2022 will take place on November 1-3 at Messe Frankfurt, Germany. We’ll be happy to meet you at our stand 80B70 at any time during the event. The arrangement of prescheduled meetings is highly appreciated. Please contact our team to request a meeting or send a meeting request to cphi@aet.eu.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER API + INGREDIENTS: Employee benefits and climate reduction goals
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Environmentally friendly and health-promoting – we offer bike leasing to employees
Employees benefits while reducing our impact on the environment with climate reduction goals – we take action on many fronts.
We take care of health and wellbeing as much as possible – and we aim to be an attractive employer by offering everyone additional benefits and wellbeing. From racing bikes to E-bikes: since this year all our employees at our Hamburg headquarters can choose from a broad range of company bikes to lease. A great opportunity for everyone to stay fit and healthy and fully aligned with TIEFENBACHER GROUP´s strategy of doing business sustainable! As with car leasing, the monthly instalment is deducted from the monthly gross salary through salary conversion.
We are very optimistic to reach soon our target that at least 30% of our Hamburg employees will cycle to work instead of taking their car. One step further on our way to less CO2 emissions! And of course, we have sufficient bicycle parking spaces in our underground garage – including numerous electric charging station for electric vehicles.
We, at Tiefenbacher Group, strive to make efficient use of natural resources, to minimize the environmental impact of our operations, and to invest in environmental solutions that protect biodiversity and natural environment – especially in the countries we operate. Our Employees with strong environmental awareness play a pivotal role in accelerating corporate sustainability plans.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI)
TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI) – contribution to sustainable and responsible business
We at TIEFENBACHER GROUP are committed to promote sustainable and responsible business along the whole pharmaceutical supply chain. That’s why we are excited to become a member of PSCI – a non-profit business membership organization striving for better social, health, safety, and environmental outcomes in pharmaceutical supply chains. It follows our company´s strategy to make medicines better affordable, better available, and better than before in a sustainable way – better for people and the planet!
PSCI is a group of international pharmaceutical and healthcare companies who share together the vision of responsible supply chains. The organization was founded in 2006 and is legally established in the United States. Today PSCI already counts 63 members. For more information about the organization have a look at: PSCI (pscinitiative.org) .
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world. We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
